Avenue Therapeutics, Inc.

Watch

Share

ATXI·05360L205·US·Common Stock·Healthcare - Biotechnology-Activist

ATXI (Avenue Therapeutics, Inc.) is held by 0 institutional investors as of Q1 2025. Net institutional sentiment: Bearish.

0

Holders

$0

Total Value

0% (3)

Consensus

0 buying - 3 selling

13F: Mar 31, 2025Insider & Congress: Updated regularly

Smart Money Verdict

View all

Institutional (13F)

Insider (Form 4)

Activist (13D/13G)

Congressional (STOCK Act)

Held by 0 funds

Who's Trading

ActivistIKIkarian Capital, LLC4.1%Feb 17, 2026

ActivistFBFortress Biotech, Inc.13.4%Jan 6, 2026

View all activist filings

Top Holders

Top Holders (0)History

AllNewIncreasedHeldDecreasedExited

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
UBS Group AG	Exited	0(-100.0%)	$15,840	0.0%	-87.43%	0
WELLS FARGO & COMPANY/MN	Exited	0(-100.0%)	$1,000	0.0%	-96.03%	0
BANK OF AMERICA CORP /DE/	Exited	0(-100.0%)	$28	0.0%	-84.02%	0

3YAll

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

413 holders · $666.6B

UNHUNITEDHEALTH GROUP INC

413 holders · $186.3B

JNJJOHNSON & JOHNSON

394 holders · $391.3B

DHRDANAHER CORP DEL

392 holders · $97B

ISRGINTUITIVE SURGICAL INC

391 holders · $123.5B

TMOTHERMO FISHER SCIENTIFIC INC

391 holders · $147B

BSXBOSTON SCIENTIFIC CORP

389 holders · $76.8B

MRKMERCK & CO INC

385 holders · $208.9B

ABBVABBVIE INC

381 holders · $254.9B

ABTABBOTT LABORATORIES

380 holders · $129.1B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer